Rodolfo Daniel Cervantes-Villagrana

8PUBLICATIONS
20CO-AUTHORS
Molecular targetsCell development, proliferation and deathTraditional Chinese medicine and treatmentsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 10, 2026
Unraveling Resistance Mechanisms to Gαq Pathway Inhibition in Uveal Melanoma: Insights from Signaling-Activation Library Screening.

Simone Lubrano, Rodolfo Daniel Cervantes-Villagrana, Nadia Arang

|Dec 23, 2023
Akt Is Controlled by Bag5 through a Monoubiquitination to Polyubiquitination Switch.

Ismael Bracho-Valdés, Rodolfo Daniel Cervantes-Villagrana, Yarely Mabell Beltrán-Navarro

|Nov 14, 2023
Oncogenic Gαq activates RhoJ through PDZ-RhoGEF.

Rodolfo Daniel Cervantes-Villagrana, Víctor Manuel Color-Aparicio, Alejandro Castillo-Kauil

|Oct 28, 2023
Cytotoxic and Antitumor Effects of the Hydroalcoholic Extract of Tagetes erecta in Lung Cancer Cells.

Alma Sarahi Cuellar González, Marisol Galván Valencia, Rodolfo Daniel Cervantes-Villagrana

|Jun 20, 2020
Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies.

Rodolfo Daniel Cervantes-Villagrana, Damaris Albores-García, Alberto Rafael Cervantes-Villagrana

|Mar 21, 2019
Direct targeting of Gαq and Gα11 oncoproteins in cancer cells.

Suvi Annala, Xiaodong Feng, Naveen Shridhar

Pageof 2

Frequent Collaborators

3 joint publications

José Vázquez-Prado

2 joint publications

Evi Kostenis

2 joint publications

J Silvio Gutkind

1 joint publications

Suvi Annala